Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(20/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(20/week)
News
United States
(558/week)
Manufacturing
(388/week)
Energy
(305/week)
Technology
(408/week)
Other Energy
(276/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
CXCR4 antagonist
May 27, 2020
BioLineRx Announces Publication of Data from Ongoing COMBAT/KEYNOTE-202 Clinical Trial in Nature Medicine
Jan 22, 2020
BioLineRx Completes Recruitment in Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Metastatic Pancreatic Cancer
Jan 14, 2020
BioLineRx Receives Orphan Drug Designation for Motixafortide (BL-8040) for the Treatment of Pancreatic Cancer in Europe
Dec 13, 2019
BioLineRx Announces Updated Phase 2a Data From Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Metastatic Pancreatic Cancer
Dec 05, 2019
BioLineRx Announces Preliminary Phase 2a Data from Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Second Line Patients With Metastatic Pancreatic Cancer
Nov 26, 2019
BioLineRx to Host Investor and Analyst Breakfast Meeting on December 5, 2019 in New York
Nov 05, 2019
BioLineRx Presents Preclinical Data From Triple Combination of BL-8040, Anti PD-1 and Chemotherapy Demonstrating Significant Reduction in Pancreatic Tumor Growth and Favorable Changes in Tumor Microenvironment
Nov 05, 2019
BioLineRx Announces BL-8040 in Combination With KEYTRUDA Shows Clinical Activity in Heavily Pretreated Metastatic Pancreatic Cancer Patients
Oct 31, 2019
BioLineRx to Present Two Posters at the Society for Immunotherapy of Cancer (SITC) 2019
Oct 29, 2019
BioLineRx to Deliver Oral Presentation at ESMO Immuno-Oncology Congress 2019
Sep 03, 2019
BioLineRx Successfully Completes Dose-Escalation Part of Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors
Feb 12, 2019
Frost & Sullivan Publishes Immediate Report on BiolineRx
Feb 04, 2019
BioLineRx Receives Orphan Drug Designation From the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer
Dec 11, 2018
BioLineRx Announces Initiation of Triple Combination Arm of Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Under Immuno-Oncology Collaboration
Dec 06, 2018
BioLineRx to Host Investor and Analyst Breakfast Meeting on December 11, 2018 in New York
Nov 01, 2018
BioLineRx to Report Third Quarter 2018 Results on November 8, 2018
Oct 20, 2018
BioLineRx Discloses Additional Data from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress
Oct 03, 2018
BioLineRx Increases Stake in BL-8040, its Lead Oncology Platform in Late Stage Development for Multiple Oncology Indications
Jul 30, 2018
BioLineRx Announces Expansion of Immuno-Oncology Collaboration in Pancreatic Cancer
May 17, 2018
BioLineRx to Present Overall Survival Data at EHA from Phase 2a Study of BL-8040 in r/r AML Patients
Page 1
››
Latest News
May 15, 2024
Rogers Corporation to Participate in Upcoming Investor Conferences
May 15, 2024
Stonepeak and CHC Form Japanese Battery Energy Storage Platform
May 15, 2024
Evan Williams Bourbon announces 2024 class of American-Made Heroes to be featured on bottles nationwide
May 15, 2024
Janus International to Participate in Upcoming Investor Conferences
May 15, 2024
EnerVest Sale of 12,000,000 Shares of Class A Common Stock of Magnolia; Magnolia to Purchase 3,000,000 Shares...
May 15, 2024
Westwater Resources Announces Business Update Conference Call
May 15, 2024
Verde Clean Fuels, Inc. Reports First Quarter 2024 Results
May 15, 2024
Seadrill Announces First Quarter 2024 Results
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events